ORGANOGENESIS HOLDINGS INC. Debt Instrument, Face Amount
ORGANOGENESIS HOLDINGS INC. (ORGO) had Debt Instrument, Face Amount of $850.00 thousand as of 2018-08-30, per its 10-Q filed 2018-11-09.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFaceAmount · last filed 2018-11-09
- 2018-08-30: Debt Instrument, Face Amount $850.00K.
- 2018-05-03: Debt Instrument, Face Amount $600.00K.
- 2017-12-31: Debt Instrument, Face Amount $100.00K.
- 2017-08-11: Debt Instrument, Face Amount $300.00K.
| Period end | Debt Instrument, Face Amount |
|---|---|
| 2018-08-30 | $850.00K 10-Q · filed 2018-11-09 |
| 2018-05-03 | $600.00K 10-Q · filed 2018-08-07 |
| 2017-12-31 | $100.00K 10-K · filed 2018-03-14 |
| 2017-08-11 | $300.00K 10-K · filed 2018-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |